Quarterly report pursuant to Section 13 or 15(d)

Note 11 - Segment Reporting Financial Information (Details)

v3.5.0.2
Note 11 - Segment Reporting Financial Information (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Corporate Clinics [Member]        
Corporate clinics $ 2,137,000 $ 624,000 $ 3,796,000 $ 1,011,000
Corporate clinics (1,651,000) (588,000) (3,335,000) (584,000)
Depreciation and amortization 534,000 199,000 1,027,000 257,000
Franchise Operations [Member]        
Corporate clinics 2,837,000 2,802,000 5,443,000 4,924,000
Corporate clinics 1,013,000 1,117,000 2,080,000 1,791,000
Depreciation and amortization
Corporate Segment [Member]        
Depreciation and amortization 103,000 80,000 186,000 144,000
Operating Segments [Member]        
Corporate clinics (638,000) 529,000 (1,255,000) 1,207,000
Corporate, Non-Segment [Member]        
Corporate clinics (2,553,000) (2,375,000) (5,421,000) (4,968,000)
Corporate clinics 4,974,041 3,426,746 9,239,077 5,934,645
Corporate clinics (3,190,987) (1,846,059) (6,676,647) (3,761,282)
Depreciation and amortization 637,115 278,502 1,212,659 401,098
Other income (expense), net 3,000 (10,000) 8,000 2,000
Loss before income tax (expense) benefit $ (3,187,912) $ (1,855,870) $ (6,668,648) $ (3,759,593)